Client News

[Accesswire] - Precision Medicine Company with Pipeline of Targeted Agents; Report Available here: www.lifescicapital.com/equity-research/ignyta/ NEW YORK, NY / ACCESSWIRE / May 29, 2015 / LifeSci Capital, LLC, a research-driven ...
Posted: May 29, 2015, 2:50 pm
Posted: May 29, 2015, 1:25 pm
[at noodls] - May 29, 2015 - NeoStem, Inc. (Nasdaq:NBS) ('NeoStem' or the 'Company'), a biopharmaceutical company developing novel cell-based individualized medicine therapies, today announced plans to change its corporate ...
Posted: May 29, 2015, 12:56 pm
[GlobeNewswire] - NEW YORK -- NeoStem, Inc. ("NeoStem" or the "Company"), a biopharmaceutical company developing novel cell-based individualized medicine therapies, today announced plans to change its ...
Posted: May 29, 2015, 12:26 pm
[PR Newswire] - VANCOUVER, British Columbia and MENLO PARK, Calif., May 29, 2015 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" and the "Company"), a biopharmaceutical company ...
Posted: May 29, 2015, 11:35 am
[GlobeNewswire] - RUTHERFORD, N.J. -- Cancer Genetics, Inc. ("CGI" or "The Company"), an emerging leader in DNA-based cancer diagnostics, announced today the presentation of results from a research collaboration ...
Posted: May 29, 2015, 11:30 am
Posted: May 29, 2015, 10:01 am
[at noodls] - NEW YORK, May 28, 2015 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML) today announced top-line results from the lead-in stage of its ongoing SL-401 pivotal trial in blastic plasmacytoid ...
Posted: May 28, 2015, 8:38 pm
[GlobeNewswire] - NEW YORK -- Stemline Therapeutics, Inc. today announced top-line results from the lead-in stage of its ongoing SL-401 pivotal trial in blastic plasmacytoid dendritic cell neoplasm (BPDCN). These results ...
Posted: May 28, 2015, 8:15 pm
Posted: May 28, 2015, 5:42 pm
[at noodls] - PRESS RELEASE Adocia to Present Positive Clinical Results for BioChaperone® Lispro at the American Diabetes Association 75th Scientific Sessions on June 6th 2015 A poster disclosing final results for the ...
Posted: May 28, 2015, 4:36 pm
Posted: May 28, 2015, 3:19 pm
[at noodls] - San Francisco, CA (May 28, 2015) Kindred Biosciences, Inc. (NASDAQ: KIN) today announced the appointment of Jennifer Elliott as Vice President of Legal Affairs and Intellectual Property. ... This is an ...
Posted: May 28, 2015, 1:46 pm
[PR Newswire] - Dr. Elliott joins KindredBio from Genentech, where she most recently served as Associate General Counsel and Director of Patent Law. She had increasing levels of responsibility in her nearly 10 year tenure with Genentech, and most recently oversaw Genentech's oncology intellectual property group.
Posted: May 28, 2015, 1:02 pm
[at noodls] - TEL AVIV, Israel, May 28, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive disorders, ...
Posted: May 28, 2015, 12:36 pm
[at noodls] - REDWOOD CITY, Calif., May 28, 2015 (GLOBE NEWSWIRE) -- ZS Pharma, Inc. (Nasdaq:ZSPH), a biopharmaceutical company focused on the development and commercialization of highly selective, non-absorbed drugs ...
Posted: May 28, 2015, 12:26 pm